About
Wayfinder at 53 Stations who participated in panel discussions on energy transition and advanced nuclear power at the 2026 portfolio summit.
Experience
- PermiraSenior Advisorcurrent2026 β presentLondon Area, United Kingdom & New York, NY
- UChicago MedicineBoard Trusteecurrent2025 β present
- AnswersNowBoard Membercurrent2022 β present
- VitestroAdvisorcurrent2024 β present
- Palvella TherapeuticsFounding Investorcurrent2016 β present
- Magee VenturesPrincipalcurrent2021 β presentChicago, Illinois, United States
- 53 StationsAdvisor2025 β 2026Chicago, IL
- BinaxityAdvisor2024 β 2025
- KinnosBoard Chair2022 β 2025New York, NY
- 3NT MedicalAdvisor2012 β 2025
- Flik TherapeuticsBoard Member2024 β 2025
- Kapor CapitalAdvisor2022 β 2024Oakland, California, United States
- Partum HealthAdvisor2021 β 2023Chicago, Illinois, United States
- BDAdvisor2021
- Velano Vascular, Inc.Chief Executive Officer & Co-founder2011 β 2021San Francisco, CA
- Crohn's & Colitis FoundationNational Trustee & Executive Committee Member2013 β 2020New York, New York, United States
- Vigilant Biosciences, Inc.Director, Board of Directors2011 β 2018
- MolecularHealthVice President, Sales and Marketing2011 β 2013New York, NY
- Harvard Alumni AssociationDirector & Committee Chair2003 β 2013Cambridge, MA
- Abbott VascularProduct & Commercial Marketing2007 β 2011San Francisco Bay Area and Brussels, Belgium
- The Magee GroupPrincipal2003 β 2005Boston, MA
- Model N, Inc.Sr. Business Development/Marketing Manager, Life Sciences2000 β 2002Redwood Shores, CA
- Trilogy, CarOrder.comMarketing Manager1999 β 2000Austin, TX
Skills & more
Business Development44Product Management17Marketing Strategy4Business Strategy9Commercialization6Competitive Analysis6Start-ups46Marketing4Management16Strategy32
From Phill's professional profile.
Colleagues at 53 Stations
Frequently asked questions
- Who is Phill Lawson-Shanks?
- Wayfinder at 53 Stations who participated in panel discussions on energy transition and advanced nuclear power at the 2026 portfolio summit.
- Where does Phill Lawson-Shanks work?
- Phill Lawson-Shanks is Wayfinder at 53 Stations.
- Where did Phill Lawson-Shanks go to school?
- Phill Lawson-Shanks studied at The Wharton School (MBA, Health Care Management); Harvard University (Ed.M., Human Development & Leadership); University of Pennsylvania (BA, English/Psychology).
Same school
Also attended The Wharton School1,557
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,551 more
Also attended Harvard University1,558
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation
+ 1,552 more
Also attended University of Pennsylvania824
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 818 more
Shared employers
Also worked at AnswersNow3
Also worked at Vitestro1
Also worked at BD21
Matthew McCooeChief Executive Officer at Connecticut InnovationsIan ChiangPartner at Flare Capital PartnersPaola RetesVice President at LiveOak VenturesMarsha HartmanExecutives in Residence at GENERAL INCEPTIONNatalie WisniewskiCompany Building Partner at Material ImpactSean SullivanT1D Moonshot Impact Board at StartUp Health
+ 15 more
Also worked at Abbott Vascular62
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalCharles BeyrouthyFounder & Managing Partner at Forma PrimeFederico RaneroVenture Partner at NazcaJennifer SmoterChief Communications & Governance Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures
+ 56 more















































